Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. The Company's first FDA cleared commercial product, RESONIC™, will use rapid pulses of acoustic shockwaves for the treatment of cellulite and as an accessory to lasers for the removal of unwanted tattoos. The Company is based in Houston, Texas, and is actively engaged in bringing RESONIC to the market. The Company believes this "Soliton" method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods. The Company also believes the technology will provide the first non-invasive acoustic technology to target the underlying causes of dimples and ridges in cellulite. Soliton is investigating potential additional capabilities of the RAP technology. The device is currently cleared in the United States only for use in tattoo removal and cellulite.
Company Details
- Employees
- 9
- Address
- 5304 Ashbrook Dr, Houston,texas 77081,united States
- Industry
- Medical Device
- Website
- soliton.com
- HQ
- Houston, Texas
Soliton, Inc. Questions
Soliton, Inc.'s website is soliton.com
Soliton, Inc.'s LinkedIn profile is https://www.linkedin.com/company/solitoninc
Soliton, Inc. has
9 employees.
View email and phone details for 9
employees at Soliton, Inc..
Soliton, Inc.'s industry is
Medical Device
Soliton, Inc.'s top competitors are
Zo Skin Health, Inc.,
Cutera, Inc.,
Soliton Technologies,
Galderma,
Merz Aesthetics,
Allergan Aesthetics, An Abbvie Company,
Soliton It,
Autonomix Medical,
Allergan,
Soliton Technologies.
Soliton, Inc.'s categories are Medical Device
